Skip to main content

Faeth Therapeutics, Inc.

FTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001829802

No open-market purchases or sales by Faeth Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Faeth Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of FTH: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders42138−3
Shares3.53M14.8K3.41M−108.5K (−3.1%)
Value$37.1M$156.0K$19.7M−$17.2M (−46.6%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Faeth Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to FTH in Q4 2021
InstitutionSharesValue% of portfolio
Two Sigma Investments, LP28,771$167.0K0.00%
Two Sigma Advisers, LP20,000$116.0K0.00%
Virtu Financial LLC15,980$93.0K0.01%
Cubist Systematic Strategies, LLC12,804$74.0K0.00%
Jump Financial, LLC11,800$68.0K0.00%
Goldman Sachs Group Inc11,098$64.0K0.00%
Point72 Hong Kong Ltd772$4.00K0.00%
Snowden Capital Advisors LLC200$1.00K0.00%
Toronto Dominion Bank2$00.00%
Ellevest, Inc.18$00.00%

Sold out (13)

Institutions that held Faeth Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of FTH in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Citadel Advisors LLC123,258$1.30M
Moore Capital Management, LP49,341$519.0K
Alps Advisors Inc37,484$394.0K
Mission Creek Capital Partners, Inc.32,784$345.0K
Tao Capital Management LP32,784$345.0K
Pura Vida Investments, LLC22,603$238.0K
Manufacturers Life Insurance Company, The13,478$142.0K
SG Americas Securities, LLC12,614$133.0K
Jane Street Group, LLC10,773$113.0K
US Bancorp91$1.00K
Signaturefd, LLC142$1.00K
Parallel Advisors, LLC54$1.00K
Lindbrook Capital, LLC27$0

Not filed for Q4 2021 yet (1)

Institutions that held Faeth Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FTH in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
BFT Financial Group, LLC14,845$156.0K